Ever since a deadly outbreak of fungal meningitis and spinal infections were linked back to the Massachusetts-based New England Compounding Center, national and state health officials have taken to monitoring similar companies even closer.
One name to emerge from the heightened watchfulness is Pallimed Pharmacy.
The company announced on March 25 that it planned to recall over a dozen products used for erectile dysfunction, hormone replacement therapy and eye treatment due to initial reports conducted by state and federal regulators.
In particular, health inspections have shown that the level of sterility necessary for processing and packaging many of the company's products is not being met, according to boston.com.
In a press release Pallimed Pharmacy describes their decision to recall the possibly tainted products as "aggressive" and "precautionary."
"Pallimed has always placed patient safety as its highest priority," it states.
The recall only applies to products dispensed on or after Jan. 1. Meanwhile, the company will continue to produce all non-sterile products as before.
Thus far, no one has been reported sick or injured in any other way by the company's products.
Meanwhile, the death toll continues to rise for those infected by steroid injections produced by the New England Compounding Center. To date, 722 have been infected and 50 have died. Of the states affected, Michigan tops the charts with 255 cases and is followed by Tennessee at 150. Nearly all of the East Coast has seen at least one case, except for Connecticut, Maine and Massachusetts.